-
Something wrong with this record ?
Parthenogenetic activation of pig oocytes using pulsatile treatment with a nitric oxide donor
J. Petr, E. Chmelíková, T. Krejcová, D. Rehák, B. Novotná, F. Jílek
Language English Country Germany
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Nitric Oxide Donors administration & dosage MeSH
- Embryo Culture Techniques veterinary MeSH
- Cells, Cultured MeSH
- Oocytes drug effects physiology MeSH
- Parthenogenesis drug effects physiology MeSH
- Swine MeSH
- S-Nitroso-N-Acetylpenicillamine administration & dosage MeSH
- Cleavage Stage, Ovum MeSH
- Animals MeSH
- Check Tag
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
The nitric oxide donor (+)-S-nitroso-N-acetylpenicillamine (SNAP) is capable of inducing parthenogenetic activation in pig oocytes matured in vitro. However, quite a long exposure to the nitric oxide donor, exceeding 10 h, is necessary for successful oocyte activation. Repeated short-term treatment with 2 mm SNAP significantly increased the activation rates despite the fact that the overall exposure time to the nitric oxide donor did not exceed 4 h. With regard to the activation rate, 12 repeated treatments lasting 10 min each were found to be the most efficient regimen (63.3%). The continuous exposure to the nitric oxide donor for the same overall time induced parthenogenetic activation in 12.5% oocytes (2-h continuous treatment with 2 mm SNAP). The development of parthenogenetic embryos increased after repeated short-term treatment with SNAP. After continuous treatment with 2 mm SNAP for 10 h, only 6.7% of the oocytes cleaved, and none developed beyond the 4-cell stage. Thirty-minute treatment repeated four times with 2 mm SNAP induced cleavage in 37.5% of the oocytes, 18.3% developed to the morula stage, and 6.7% reached the blastocyst stage. Based on the results, it is concluded that pulsatile treatment can significantly improve parthenogenetic activation rate when compared with the continuous treatment using nitric oxide donors.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12026061
- 003
- CZ-PrNML
- 005
- 20130124153618.0
- 007
- ta
- 008
- 120817s2010 gw f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1111/j.1439-0531.2008.01275.x $2 doi
- 035 __
- $a (PubMed)18992113
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Petr, J $u Research Institute of Animal Production, Prátelství, Czech Republic.
- 245 10
- $a Parthenogenetic activation of pig oocytes using pulsatile treatment with a nitric oxide donor / $c J. Petr, E. Chmelíková, T. Krejcová, D. Rehák, B. Novotná, F. Jílek
- 520 9_
- $a The nitric oxide donor (+)-S-nitroso-N-acetylpenicillamine (SNAP) is capable of inducing parthenogenetic activation in pig oocytes matured in vitro. However, quite a long exposure to the nitric oxide donor, exceeding 10 h, is necessary for successful oocyte activation. Repeated short-term treatment with 2 mm SNAP significantly increased the activation rates despite the fact that the overall exposure time to the nitric oxide donor did not exceed 4 h. With regard to the activation rate, 12 repeated treatments lasting 10 min each were found to be the most efficient regimen (63.3%). The continuous exposure to the nitric oxide donor for the same overall time induced parthenogenetic activation in 12.5% oocytes (2-h continuous treatment with 2 mm SNAP). The development of parthenogenetic embryos increased after repeated short-term treatment with SNAP. After continuous treatment with 2 mm SNAP for 10 h, only 6.7% of the oocytes cleaved, and none developed beyond the 4-cell stage. Thirty-minute treatment repeated four times with 2 mm SNAP induced cleavage in 37.5% of the oocytes, 18.3% developed to the morula stage, and 6.7% reached the blastocyst stage. Based on the results, it is concluded that pulsatile treatment can significantly improve parthenogenetic activation rate when compared with the continuous treatment using nitric oxide donors.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a kultivované buňky $7 D002478
- 650 _2
- $a stadium rýhování vajíčka $7 D002970
- 650 _2
- $a kultivace embrya $x veterinární $7 D046149
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a donory oxidu dusnatého $x aplikace a dávkování $7 D020030
- 650 _2
- $a oocyty $x účinky léků $x fyziologie $7 D009865
- 650 _2
- $a partenogeneze $x účinky léků $x fyziologie $7 D010312
- 650 _2
- $a S-nitroso-N-acetylpenicilamin $x aplikace a dávkování $7 D026423
- 650 _2
- $a prasata $7 D013552
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Chmelíková, Eva, $d 1978- $7 xx0053680
- 700 1_
- $a Krejcová, T
- 700 1_
- $a Rehák, D
- 700 1_
- $a Novotná, B
- 700 1_
- $a Jílek, F
- 773 0_
- $w MED00007347 $t Reproduction in domestic animals = Zuchthygiene $x 1439-0531 $g Roč. 45, č. 3 (2010), s. 493-9
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/18992113 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20130124153738 $b ABA008
- 999 __
- $a ok $b bmc $g 948103 $s 783407
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 45 $c 3 $d 493-9 $i 1439-0531 $m Reproduction in domestic animals $n Reprod Domest Anim $x MED00007347
- LZP __
- $a Pubmed-20120817/10/03